Follow the Pundits
Tag: Institutional Investors
🌲 Lone Pine Capital: Inside Steve Mandel’s $25B Tiger Cub Masterclass (+43% Surge in 1H 2026) 🏹
Steve Mandel’s Lone Pine Capital surged 43% in the first half of 2026. We dig into the $25B+ Tiger Cub’s Q2 portfolio, Nebius and Home Depot bets, long-term record, management obsession—and why “duration” may be its most important edge.
🏒 Glenview Capital & Larry Robbins: The $5.5B “Hockey Jersey” Hedge Fund Slashing Wall Street 🏥⚡
Larry Robbins has built Glenview Capital around fundamental research, concentrated conviction and an unusual willingness to act like an owner. We examine its ~$5.5B Q2 2026 portfolio, CVS activism, healthcare bets, extraordinary early track record—and why hockey may explain more about Robbins than you'd expect. 🏒
Baillie Gifford Review 2026: The Long-Term Kings of Disruptive Growth 🏴☠️
Baillie Gifford invests like a time traveler—betting on companies that could dominate the next decade. But with great upside comes serious volatility. Here’s the full 2026 breakdown.
Will Billionaire Investor Ron Baron's Investment in Figs, Inc. (FIGS) Finally Bear Fruit?
Billionaire investor Ron Baron is doubling down on Figs, Inc. (FIGS) 🧵—the scrubs brand he calls the “Lululemon of healthcare.” With 94% institutional ownership, growing global expansion, and strong financials, could FIGS finally bear fruit 🍇? Or will competition and lofty valuation trip it up? Here’s the breakdown—fun, funny, and icon-filled.
Warren Buffett’s Berkshire Hathaway and Renaissance Like Verisign. Should You Register Too?
Berkshire bought big. Renaissance holds strong. Is Verisign (VRSN) a quiet winner—or is the best already priced in? Let’s decode the signals.